FDG PET/MRI Evaluation of Facet Joint Pain
Molecular and Magnetic Resonance Imaging Biomarkers of Facet Joint Pain of the Lumbar Spine With PET/MRI
1 other identifier
interventional
10
1 country
1
Brief Summary
Chronic pain incurs over half a trillion dollars in lost productivity (healthcare, lost wages, etc) annually. The most common source is low back pain (LBP), often from facet joints. The clinical evaluation of facet joints is challenging and anatomic imaging findings of facet joint; degenerative change; correlate poorly with pain. Therefore, it is difficult to select appropriate candidate patients/facet joints to treat. Misguided percutaneous treatment can cost thousands of dollars per session and delay diagnoses. Very limited retrospective information suggests that high grade peri-facet MRI signal change correlates to the side of LBP. However, this has not fully characterized the imaging findings and has not correlated to expert clinical exam/percutaneous response, precluding robust and meaningful clinical impact. Minimal retrospective data concludes inflammatory changes can be identified on FDG-PET exams, but the evidence of correlation to patient pain is lacking. Limited DWI exists for inflammatory spondyloarthropathies and myopathies, but is also lacking. This is an exploratory study investigating the utility of FDG PET activity and MRI signal change around facet joints in the clinical management of low back pain. This study will help determine if such imaging biomarkers could change clinical management. Additionally, this will provide data that will be vital to planning a larger prospective study evaluating the ability of imaging biomarkers to predict response to comparison medial branch blocks and RF ablation for treatment of facet joint pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable low-back-pain
Started Sep 2016
Longer than P75 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 29, 2016
CompletedFirst Posted
Study publicly available on registry
October 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedResults Posted
Study results publicly available
February 19, 2020
CompletedFebruary 19, 2020
February 1, 2020
2.2 years
September 29, 2016
January 20, 2020
February 7, 2020
Conditions
Outcome Measures
Primary Outcomes (8)
Facet Joint High Grade FDG Activity Concordance to Pain
Concordance of high grade FDG scores with clinical impression
2 years
Facet Joint All Grades of FDG Activity Concordance to Pain
Number/percentage of subjects (reported in sides, with two sides (Left or Right) per patient) for whom any grade (any evidence of increased FDG activity) of FDG scores are in concordance with clinical impression
2 years
Facet Joint High Grade MRI Signal Change Concordance to Pain
Number/percentage of subjects (reported in sides, with two sides (Left or Right) per patient) for whom any grade (any evidence of increased FDG activity) of FDG scores are in concordance with clinical impression
2 years
Facet Joint Any Grade of MRI Signal Change Concordance to Pain
Number/percentage of subjects (reported in sides, with two sides (Left or Right) per patient) for whom any grade (any evidence of increased FDG activity) of FDG scores are in concordance with clinical impression
2 years
Facet Joint High Grade FDG Activity Potential Effect on Management
Number/percentage of subjects for whom high grade FDG scores would change clinical management
2 years
Facet Joint All Grades of FDG Activity Potential Effect on Management
Number/percentage of subjects for whom any grade FDG scores would change clinical management
2 years
Facet Joint High Grade MRI Signal Change Potential Effect on Management
Number/percentage of subjects for whom high grade MRI facet joint signal change would change clinical management
2 years
Facet Joint Any Grade MRI Signal Change Potential Effect on Management
Number/percentage of subjects for whom any grade MRI facet joint signal change would change clinical management
2 years
Study Arms (1)
PET/MR recipients
EXPERIMENTALAll recruited patients will undergo FDG PET/MR of the lumbar spine as the single arm of the study.
Interventions
All recruited patients will undergo an FDG PET examination focused on the lumbar spine.
Eligibility Criteria
You may qualify if:
- Male and female patients over the age of 50-100 years with clinically suspected facetogenic low back pain.
- Patients must be considered to have at least a 60% chance of having facet joints as the major source of low back pain based on overall clinical impression.
- All patients will undergo a standardized clinical exam by an experienced physical medicine and rehabilitation clinician to confirm clinical suspicion of axial low back pain.
- Patients with either unilateral or bilateral axial low back pain may be enrolled.
You may not qualify if:
- Pregnancy
- Prior lumbar back surgery
- History of endovascular repair of abdominal aortic aneurysm or other postoperative change likely to introduce imaging artifact to the lumbar spine
- Suspected spine infection
- Known osseous metastatic or other osseous malignancy
- Facet joint percutaneous treatment within the past 2 months
- History of major lumbar spine trauma
- Inability to provide own consent
- Claustrophobia, cardiac pacemaker/wires in place, any absolute contraindication to MRI
- Impaired renal function indicated by a GFR less than 30
- Gadolinium allergy
- Highly radiosensitive medical conditions
- Patients who are unable to lay quietly for 60 minutes of imaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Vance Lehman
- Organization
- Mayo Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
Vance T Lehman
Mayo Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D. , Assistant Professor of Radiology
Study Record Dates
First Submitted
September 29, 2016
First Posted
October 3, 2016
Study Start
September 1, 2016
Primary Completion
November 1, 2018
Study Completion
October 1, 2019
Last Updated
February 19, 2020
Results First Posted
February 19, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share